News
Hopes rise for a new treatment option for people living with lupus, after UCB and Biogen reveal phase 3 data with their anti-CD40L antibody DZP.
Complete Alphabet Inc. Cl C stock information by Barron's. View real-time GOOG stock price and news, along with industry-best analysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback